Daojiang Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 7
- Circular RNAs in diseases 4
- Cancer-related gene regulation 4
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Co-authors
- Changwei Lin (13 shared papers)Chunxing Yang (9 shared papers)Yi Zhang (6 shared papers)Xiaorong Li (12 shared papers)Yang Bai (6 shared papers)Runliu Wu (6 shared papers)Wanwan Li (2 shared papers)Lihua Huang (2 shared papers)
- Journals
- Oncotarget (5 papers)OncoTargets and Therapy (4 papers)Frontiers in Oncology (3 papers)Oncology Reports (2 papers)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Daojiang Li
29 papers receiving 744 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 429
- Molecular Biology 636
- Oncology 91
- Pathology and Forensic Medicine 54
- Immunology 43
Countries citing papers authored by Daojiang Li
This map shows the geographic impact of Daojiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daojiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daojiang Li more than expected).
Fields of papers citing papers by Daojiang Li
This network shows the impact of papers produced by Daojiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daojiang Li. The network helps show where Daojiang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Daojiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 202 | |
| 2 | 2016 | 46 | |
| 3 | Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer. | 2014 | 42 |
| 4 | 2017 | 39 | |
| 5 | 2018 | 38 | |
| 6 | 2014 | 37 | |
| 7 | 2018 | 35 | |
| 8 | 2019 | 34 | |
| 9 | 2018 | 34 | |
| 10 | MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression. | 2015 | 31 |
| 11 | 2017 | 27 | |
| 12 | 2019 | 25 | |
| 13 | 2018 | 25 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 20 | |
| 16 | 2018 | 19 | |
| 17 | 2018 | 15 | |
| 18 | 2015 | 11 | |
| 19 | 2017 | 10 | |
| 20 | 2019 | 7 |
About Daojiang Li
Daojiang Li is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Surgery and Oncology, having authored 34 papers that have together received 751 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (7 papers), Circular RNAs in diseases (4 papers), Cancer-related gene regulation (4 papers), Genetic factors in colorectal cancer (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (429 citations), Molecular Biology (636 citations), Oncology (91 citations), Pathology and Forensic Medicine (54 citations) and Immunology (43 citations). Daojiang Li has collaborated with scholars based in China and United States. Frequent co-authors include Changwei Lin, Chunxing Yang, Yi Zhang, Xiaorong Li, Yang Bai, Runliu Wu, Wanwan Li, Lihua Huang, Zhengrong Li and Su Chen. Their work appears in journals such as Oncotarget, OncoTargets and Therapy, Frontiers in Oncology, Oncology Reports and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.